Could a tweak to an implanted device ease stomach pain?

NCT ID NCT07556237

Not yet recruiting Symptom relief Sponsor: University of Louisville Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether changing the settings on an already-implanted stomach pacemaker (Enterra™) can reduce chronic abdominal pain in people with gastroparesis, a condition where the stomach empties slowly. Researchers will randomly assign 150 adults to one of three stimulation programs and track their pain, symptoms, and quality of life over 8 weeks. The goal is to find a better way to manage pain without extra medications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Enterra™ neurostimulator (implanted device)
What this could lead to: If successful, this could provide a new way to manage chronic abdominal pain in people with gastroparesis without adding new drugs.
What could go wrong: This is a small, early-stage study testing different programming settings on an already-approved device. It may not show a clear benefit for pain, and results may not apply to everyone with gastroparesis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC ABDOMINAL PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastroparesis Visceral Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC ABDOMINAL PAIN GASTROPARESIS

Contacts and locations

Locations

University of Louisville Clinical Trials Unit

Louisville, Kentucky, 40202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.